Investors

Codex DNA

Codex DNA is a leading synthetic biology company enabling customers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. A key part of our solution is our BioXp system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. The BioXp system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.

Investor Relations Contacts

Richard Lepke Image
Richard Lepke
RichardL@codexdna.com
619-840-5392

About Codex DNA

Codex DNA, Inc. is building biology. Creators of the BioXp system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly® method, Codex DNA, Inc. is focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.

Codex DNA, Inc. is accelerating advances in the fields of personalized medicine, biologics drug discovery, vaccine development, genome editing, and cell and gene therapy.


All trademarks are the property of Codex DNA, Inc. or their respective owners. For specific trademark information, contact us at help@codexdna.com.
All content © 2021 Codex DNA, Inc. All rights reserved.

Codex DNA Logo